| (Values in U.S. Thousands) | Aug, 2023 | Aug, 2022 | Aug, 2021 | Aug, 2020 | Aug, 2019 |
| Sales | 67 | 29 | 0 | 0 | 0 |
| Sales Growth | +132.62% | unch | unch | unch | unch |
| Net Income | -3,310 | -5,990 | -3,334 | -330 | -77 |
| Net Income Growth | +44.75% | -79.67% | -910.63% | -327.71% | unch |
Cellular Goods Plc (CBX.LN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [LSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Cellular Goods PLC develops efficacy-led and research-backed cannabinoid products. The company is launching with two product brands covering distinct market segments: a face-mask and serum-containing synthetic CBD, and a topical athletic recovery gel roll-on product. These will be made available through partnerships with online and physical retailers and direct to consumers through the company's website.